CRISPR/Cas9-Induced Loss of Keap1 Enhances Anti-oxidation in Rat Adipose-Derived Mesenchymal Stem Cells

Frontiers in Neurology
Yiling HuBing-Mei Zhu

Abstract

Stem cells have become a powerful tool in the treatment of many diseases owing to their regenerative ability and rapid promotion of development in regenerative medicine such as in traumatic brain injury. However, the high level of oxidant micro-environment in lesion region leads to more than 99% cells into death. In this study, we used genetic methods to edit Keap1 gene in mesenchymal stem cells, we and observed their antioxidative ability. First, we disturbed the start codon and the 376th amino acid codon of Keap1 in adipose-derived mesenchymal stem cells (Ad-MSCs) with CRISPR/Cas9, respectively, to release Nrf2 from the binding of Keap1. As a result, Nrf2 was activated and localized into nuclei and regulated cellular anti-oxidation. We observed that the cells lacking Keap1 ATG codon showed obvious nuclear localization of Nrf2. Besides lower expression of Bax-1 and lower content of malondialdehyde (MDA) were detected after H2O2 treatment, we also found higher expression of Bcl-2 in Keap1 ATG codon knock-out cells, whereas a higher expression of PCNA was observed only in the Keap1 376th codon-edited cells, whose Bax-1 expression was lower than that in the control cells. Our study revealed that loss of Keap1 resulted in anti-oxi...Continue Reading

References

May 10, 2001·Journal of Molecular and Cellular Cardiology·M ZhangC E Murry
Mar 27, 2009·Trends in Biochemical Sciences·John D Hayes, Michael McMahon
Jun 3, 2010·Cold Spring Harbor Protocols·Donald C RioTimothy W Nilsen
Jan 18, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cheryl E RockwellCurtis D Klaassen
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Jul 6, 2014·Physiological Reviews·Dmitry B ZorovSteven J Sollott
Aug 15, 2014·Nucleic Acids Research·Ami M KabadiCharles A Gersbach
Dec 9, 2014·Cytokine·Alexandra E TurleyCheryl E Rockwell
Jul 4, 2015·Methods in Molecular Biology·Vince Boveia, Amy Schutz-Geschwender
Nov 5, 2015·Current Opinion in Organ Transplantation·Mathew G Angelos, Dan S Kaufman
Mar 10, 2017·Expert Opinion on Biological Therapy·Kay MaedaMarc Ruel
Dec 14, 2017·Drug Discovery Today. Technologies·Dieter SchmollHeiner Glombik
Apr 20, 2018·Stroke; a Journal of Cerebral Circulation·Sean I Savitz

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
fluorescence-activated cell sorting
PCR
electrophoresis
fluorescence microscopy
immunoprecipitation
MDA
Assay
FACS

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Related Papers

Genes to Cells : Devoted to Molecular & Cellular Mechanisms
Yoriko WataiMasayuki Yamamoto
The Journal of Biological Chemistry
Laurie M Zipper, R Timothy Mulcahy
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Hye-Yon ChoJae Hong No
© 2021 Meta ULC. All rights reserved